Semaglutide is not an insulin but it does help stimulate Insulin Secretion.
Semaglutide injection is in a class of medications called incretin mimetics.
The medication Semaglutide Injection works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.
Insulin helps move sugar from the blood into other body tissues where it is used for energy.
Semaglutide lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver.
Ozempic is a brand name of Semaglutide.
Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide acts like human glucagon-like peptide-1 such that it increases insulin secretion, thereby increasing sugar metabolism.
Now, semaglutide (under the brand name Wegovy) is FDA-approved for weight loss in adults with a body mass index (BMI) greater than or equal to 30mg/kg² alone or 27 mg/kg² with at least one weight-related comorbidity (e.g., high blood pressure, high cholesterol).
People can lose significant weight on semaglutide because it suppresses appetite.
Semaglutide can be taken orally or by injection, according to Novo Nordisk, and it works by increasing the production of insulin, a hormone produced by the pancreas that helps regulate blood sugar.